Local Delivery of RhoA SiRNA by PgP Nanocarrier Reduces Inflammatory Response and Improves Neuronal Cell Survival in a Rat TBI Model

Overview

Journal Nanomedicine

Publisher Elsevier

Specialties Biomedical Engineering
Biotechnology

Date 2020 Dec 1

PMID 33259960

Citations 7

Authors

Christian Macks

Daun Jeong

Jeoung Soo Lee

Affiliations

Soon will be listed here.

Abstract

Traumatic brain injury (TBI) is a leading cause of death and disability with complex pathophysiology including prolonged neuroinflammation, apoptosis, and glial scar formation. The upregulation of RhoA is a key factor in the pathological development of secondary injury following TBI. Previously, we developed a novel cationic, amphiphilic copolymer, poly (lactide-co-glycolide)-graft-polyethylenimine (PgP), as a nanocarrier for delivery of therapeutic nucleic acids. In a rat compression spinal cord injury model, delivery of siRNA targeting RhoA (siRhoA) by PgP resulted in RhoA knockdown; reduced astrogliosis and inflammation; and promoted axonal regeneration/sparing. Here, we evaluated the effect of RhoA knockdown by PgP/siRhoA nanoplexes in a rat controlled cortical impact TBI model. A single intraparenchymal injection of PgP/siRhoA nanoplexes significantly reduced RhoA expression, lesion volume, neuroinflammation, and apoptosis, and increased neuronal survival in the ipsilateral cortex. These results suggest that PgP/siRhoA nanoplexes can efficiently knockdown RhoA expression in the injured brain and reduce secondary injury.

Citing Articles

Applications of hydrogels and nanoparticles in the treatment of traumatic brain injury.

Shi J, Tang J, Xu J, Jiang N, Yang Y, Chen H Front Bioeng Biotechnol. 2025; 12():1515164.

PMID: 39834632 PMC: 11743581. DOI: 10.3389/fbioe.2024.1515164.

Nanocarrier-mediated siRNA delivery: a new approach for the treatment of traumatic brain injury-related Alzheimer's disease.

Jin J, Zhang H, Lu Q, Tian L, Yao S, Lai F Neural Regen Res. 2024; 20(9):2538-2555.

PMID: 39314170 PMC: 11801294. DOI: 10.4103/NRR.NRR-D-24-00303.

Neurotrauma-From Injury to Repair: Clinical Perspectives, Cellular Mechanisms and Promoting Regeneration of the Injured Brain and Spinal Cord.

Stevens A, Belli A, Ahmed Z Biomedicines. 2024; 12(3).

PMID: 38540256 PMC: 10968440. DOI: 10.3390/biomedicines12030643.

Nanomaterials as therapeutic agents to modulate astrocyte-mediated inflammation in spinal cord injury.

Luo W, Li Y, Xiang C, Aizawa T, Niu R, Wang Y Mater Today Bio. 2023; 23:100888.

PMID: 38075250 PMC: 10704436. DOI: 10.1016/j.mtbio.2023.100888.

Expanding Structural Space for Immunomodulatory Nucleic Acid Nanoparticles (Nanps) via Spatial Arrangement of Their Therapeutic Moieties.

Chandler M, Rolband L, Johnson M, Shi D, Avila Y, Cedrone E Adv Funct Mater. 2023; 32(43).

PMID: 37008199 PMC: 10065476. DOI: 10.1002/adfm.202205581.

References

Kubo T, Yamaguchi A, Iwata N, Yamashita T . The therapeutic effects of Rho-ROCK inhibitors on CNS disorders. Ther Clin Risk Manag. 2008; 4(3):605-15. PMC: 2500253. DOI: 10.2147/tcrm.s2907. View

Rosen G, Harry J . Brain volume estimation from serial section measurements: a comparison of methodologies. J Neurosci Methods. 1990; 35(2):115-24. DOI: 10.1016/0165-0270(90)90101-k. View

McKerracher L, Ferraro G, Fournier A . Rho signaling and axon regeneration. Int Rev Neurobiol. 2012; 105:117-40. DOI: 10.1016/B978-0-12-398309-1.00007-X. View

Bye N, Christie K, Turbic A, Basrai H, Turnley A . Rho kinase inhibition following traumatic brain injury in mice promotes functional improvement and acute neuron survival but has little effect on neurogenesis, glial responses or neuroinflammation. Exp Neurol. 2016; 279:86-95. DOI: 10.1016/j.expneurol.2016.02.012. View

Mulherkar S, Firozi K, Huang W, Uddin M, Grill R, Costa-Mattioli M . RhoA-ROCK Inhibition Reverses Synaptic Remodeling and Motor and Cognitive Deficits Caused by Traumatic Brain Injury. Sci Rep. 2017; 7(1):10689. PMC: 5587534. DOI: 10.1038/s41598-017-11113-3. View

Gwak S, Macks C, Jeong D, Kindy M, Lynn M, Webb K . RhoA knockdown by cationic amphiphilic copolymer/siRhoA polyplexes enhances axonal regeneration in rat spinal cord injury model. Biomaterials. 2017; 121:155-166. PMC: 5315572. DOI: 10.1016/j.biomaterials.2017.01.003. View

Abeysinghe H, Phillips E, Chin-Cheng H, Beart P, Roulston C . Modulating Astrocyte Transition after Stroke to Promote Brain Rescue and Functional Recovery: Emerging Targets Include Rho Kinase. Int J Mol Sci. 2016; 17(3):288. PMC: 4813152. DOI: 10.3390/ijms17030288. View

Sheikh A, Nagai A, Ryu J, McLarnon J, Kim S, Masuda J . Lysophosphatidylcholine induces glial cell activation: role of rho kinase. Glia. 2008; 57(8):898-907. DOI: 10.1002/glia.20815. View

Hsieh S, Ferraro G, Fournier A . Myelin-associated inhibitors regulate cofilin phosphorylation and neuronal inhibition through LIM kinase and Slingshot phosphatase. J Neurosci. 2006; 26(3):1006-15. PMC: 6675360. DOI: 10.1523/JNEUROSCI.2806-05.2006. View

10.

Dubreuil C, Marklund N, Deschamps K, McIntosh T, McKerracher L . Activation of Rho after traumatic brain injury and seizure in rats. Exp Neurol. 2006; 198(2):361-9. DOI: 10.1016/j.expneurol.2005.12.002. View

11.

Gutekunst C, Tung J, McDougal M, Gross R . C3 transferase gene therapy for continuous conditional RhoA inhibition. Neuroscience. 2016; 339:308-318. PMC: 5118153. DOI: 10.1016/j.neuroscience.2016.10.022. View

12.

Sun H, Tong S, He J, Wang Q, Zou L, Ma S . RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway. World J Gastroenterol. 2007; 13(25):3517-22. PMC: 4146790. DOI: 10.3748/wjg.v13.i25.3517. View

13.

Raad M, El Tal T, Gul R, Mondello S, Zhang Z, Boustany R . Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma. Electrophoresis. 2012; 33(24):3659-68. DOI: 10.1002/elps.201200470. View

14.

Donovan F, Pike C, Cotman C, Cunningham D . Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci. 1997; 17(14):5316-26. PMC: 6793831. View

15.

Clark D, Perreau V, Shultz S, Brady R, Lei E, Dixit S . Inflammation in Traumatic Brain Injury: Roles for Toxic A1 Astrocytes and Microglial-Astrocytic Crosstalk. Neurochem Res. 2019; 44(6):1410-1424. DOI: 10.1007/s11064-019-02721-8. View

16.

Chan C, Wong A, Liu J, Steeves J, Tetzlaff W . ROCK inhibition with Y27632 activates astrocytes and increases their expression of neurite growth-inhibitory chondroitin sulfate proteoglycans. Glia. 2006; 55(4):369-84. DOI: 10.1002/glia.20466. View

17.

Perez-Martinez F, Carrion B, Cena V . The use of nanoparticles for gene therapy in the nervous system. J Alzheimers Dis. 2012; 31(4):697-710. DOI: 10.3233/JAD-2012-120661. View

18.

Keane R, Kraydieh S, Lotocki G, Alonso O, Aldana P, Dietrich W . Apoptotic and antiapoptotic mechanisms after traumatic brain injury. J Cereb Blood Flow Metab. 2001; 21(10):1189-98. DOI: 10.1097/00004647-200110000-00007. View

19.

Brabeck C, Beschorner R, Conrad S, Mittelbronn M, Bekure K, Meyermann R . Lesional expression of RhoA and RhoB following traumatic brain injury in humans. J Neurotrauma. 2004; 21(6):697-706. DOI: 10.1089/0897715041269597. View

20.

Faden A, Wu J, Stoica B, Loane D . Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury. Br J Pharmacol. 2015; 173(4):681-91. PMC: 4742301. DOI: 10.1111/bph.13179. View